Advanced Biomed Inc. (ADVB)

NASDAQ: ADVB · Real-Time Price · USD

2.980

-0.060 (-1.97%)

At close: Oct 28, 2026, 4:00 PM EDT

3.010

+0.030 (1.02%)

After-hours: Oct 28, 2026, 6:04 PM EDT

Advanced Biomed Balance Sheet

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Cash & Equivalents	0.39	0.03	2.61	2.62	4.78
Cash & Short-Term Investments	0.39	0.03	2.61	2.62	4.78
Cash Growth	1138.11%	-98.81%	-0.55%	-45.18%	7156.86%
Other Receivables	13.36	-	0.21	0.15	0.16
Receivables	13.36	-	0.21	0.15	0.16
Prepaid Expenses	0	1.84	0.24	0.01	0.06
Other Current Assets	-	20.51	-	-	-
Total Current Assets	13.75	22.38	3.05	2.79	5.01
Property, Plant & Equipment	-	-	0.65	0.95	1.23
Other Intangible Assets	-	-	0.12	0.25	0.41
Long-Term Deferred Tax Assets	0	-	-	-	-
Long-Term Deferred Charges	-	-	0.64	0.55	-
Other Long-Term Assets	-	0.48	-	0.06	0.07
Total Assets	13.75	22.86	4.46	4.6	6.71

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Accounts Payable	-	-	0.62	0.63	0.76
Accrued Expenses	0.37	0.53	0.08	0.09	0.1
Short-Term Debt	1.08	-	0.78	-	-
Current Portion of Leases	-	-	0.06	0.22	0.24
Other Current Liabilities	0.02	18.71	1.18	2.34	1.89
Total Current Liabilities	1.47	19.24	2.73	3.28	2.99
Long-Term Leases	-	-	0.06	0.02	0.23
Other Long-Term Liabilities	-	0.15	-	-	-
Total Liabilities	1.47	19.38	2.8	3.29	3.22

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Common Stock	0	0	0.02	0.02	0.1
Additional Paid-In Capital	23.86	21.37	16.49	13.67	12.58
Retained Earnings	-12.56	-19.23	-15.97	-13.19	-9.46
Comprehensive Income & Other	0.97	1.34	1.12	0.8	0.27
Shareholders' Equity	12.28	3.48	1.66	1.31	3.49
Total Liabilities & Equity	13.75	22.86	4.46	4.6	6.71

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022
Total Debt	1.08	-	0.91	0.24	0.47
Net Cash (Debt)	-0.69	0.03	1.7	2.39	4.31
Net Cash Growth	-	-98.17%	-28.92%	-44.68%	7225.84%
Net Cash Per Share	-0.55	0.03	1.70	2.39	6.08
Filing Date Shares Outstanding	1.65	1.08	1	1	1
Total Common Shares Outstanding	1.65	1.08	1	1	0.99
Working Capital	12.28	3.14	0.32	-0.49	2.02
Book Value Per Share	7.43	3.21	1.66	1.31	3.53
Tangible Book Value	12.28	3.48	1.54	1.06	3.08
Tangible Book Value Per Share	7.43	3.21	1.54	1.06	3.11
Machinery	-	-	1.55	1.51	1.38
Leasehold Improvements	-	-	0.2	0.2	0.21

SEC Filings: 10-K · 10-Q